Article
Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study
12 Jan 2021
Abstract excerpt
Epstein-Barr virus-associated diseases are important global health concerns. As a group I carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial- and lymphatic-originated tumors. Moreover, EBV plays an etiological and pathogenic role in a number of non-neoplastic diseases, and is even involved in multiple autoimmune diseases (SADs). In this review, we summarize and discuss some recent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
